• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Apogee Therapeutics, Inc. - Common Stock (NQ: APGE )

    52.95 -0.39 (-0.73%)
    Official Closing Price Updated: 4:15 PM EDT, Sep 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 347,422
    Open 55.00
    Bid (Size) 21.18 (2)
    Ask (Size) 55.00 (1)
    Prev. Close 53.34
    Today's Range 52.63 - 55.00
    52wk Range 14.19 - 72.29
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
    From Apogee Therapeutics
    Via GlobeNewswire
    Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
    From Apogee Therapeutics
    Via GlobeNewswire

    Performance

    YTD
    +85.72%
    +85.72%
    1 Month
    +8.08%
    +8.08%
    3 Month
    +39.16%
    +39.16%
    6 Month
    -20.42%
    -20.42%
    1 Year
    +154.08%
    +154.08%

    More News

    Read More
    Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    APGE Stock Earnings: Apogee Therapeutics Meets EPS for Q2 2024
    Via InvestorPlace
    Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
    Via Benzinga
    Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    Apogee Therapeutics to Participate in Upcoming June Investor Conferences
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    APGE Stock Earnings: Apogee Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    Earnings Superstars: 3 Stocks Primed to Outperform This Quarter
    Via InvestorPlace
    Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
    Via Benzinga
    Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    APGE Stock Earnings: Apogee Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
    From Apogee Therapeutics, LLC
    Via GlobeNewswire
    Crude Oil Down 1%; Dave Shares Jump After Q4 Results
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Nasdaq Down 250 Points; ISM Services PMI Falls In February
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.